Male SD rats |
MCAO-induced brain damage |
In vivo
|
PARP↓, NAD↓ |
I/R injury |
Brain |
Zhang et al. (2009)
|
Female SD rats |
— |
In vivo
|
GAP43↑, PTN↓, JAK2↓, STAT↓ |
I/R injury |
Brain |
Niu et al. (2021)
|
Primary cortical neurons |
|
In vitro
|
|
|
|
|
SD rats |
MCAO-induced brain damage |
In vivo
|
p65↓, p38↓, ROS↓, MDA↓, SOD↑, CAT↑ |
I/R injury |
Brain |
Zhang et al. (2022f)
|
|
|
|
GSH-Px↑, GSH↑, IL-1↓, IL-6↓, TNF-α↓ |
|
|
|
Rats |
MCAO-induced brain damage |
In vivo
|
SOD↑, CAT↑, GSH↑, ROS↓ |
I/R injury |
Brain |
Guo et al. (2011a)
|
Rat cortical neurons |
|
In vitro
|
|
|
|
|
C57BL/6N mice |
MCAO-induced brain damage |
In vivo
|
NOX1↓, NOX2↓, NOX4↓ |
I/R injury |
Brain |
Deng et al. (2022)
|
AR−/− mice |
|
|
|
|
|
|
Male SD rats |
MCAO-induced brain damage |
In vivo
|
eNOS↑, VEGF↓, bFGF↓, iNOS↓ |
I/R injury |
Brain |
Hu et al. (2005)
|
Male SD rats |
MCAO-induced brain damage |
In vivo and in vitro
|
NOX2↓, 8-OHdG↓, 4-HNE↓, 3-NT↓ |
|
|
Sun et al. (2018c)
|
Primary astrocytes |
|
|
caspase-3↓, NeuN↓, connexin 43↑ |
|
|
|
Wistar rat, Neuronal cells |
Neuron damage induced by hydrogen peroxide |
In vitro
|
cNOS↓, NO↑ |
Neuron damage |
Brain |
Liu et al. (2005)
|
SD rats |
MCAO-induced brain damage |
In vivo
|
PKG↑ |
Cerebral ischemia |
Brain |
Chen et al. (2021b)
|
Rat brain microvascular |
— |
In vitro
|
NO↑, CD63↑, claudin 5↑, occludin↑, ZO1↑, LDH↓, ROS↓ |
Cerebral ischemia |
Brain |
Zhong et al. (2019)
|
Endothelial cells |
|
|
|
|
|
|
Rats |
MCAO-induced brain damage |
In vivo
|
XOD↓, ALT↓, AST↓, MDA↓ |
I/R injury |
Brain/Liver |
Yang et al. (2003) |
BV-2 cells, TNC1 astrocytes |
MCAO-induced brain damage |
In vitro
|
GFAP↑, Notch-1↑, NICD↑, HES-1↑, TNF-α↑, IL-1β↑, iNOS↑ |
Cerebral ischemia |
Brain |
Fang et al. (2015)
|
Male SD rats, BV-2 cells |
MCAO-induced brain damage |
In vivo and in vitro
|
NF-κB↓, Notch-1↓, NICD↓, RBP-JK↓, Hes-1↓ MCP-1↓ |
Cerebral ischemia |
Brain |
Yuan et al. (2015)
|
Male SD rats |
MCAO-induced brain damage |
In vivo and in vitro
|
p-p38↓, p-JNK↓, p-ERK1/2↑, iNOS↓, TNF-α↓, IL-1β↓ |
Cerebral ischemia |
Brain |
Chen et al. (2020)
|
BV-2 cells |
LPS induced BV-2 cells |
|
p-JNK↓, p-p38 MAPKs↓ |
|
|
|
SD rats |
MCAO-induced brain damage |
In vivo
|
ACE↓, AT1R↓, Ang II↓, TNF-α↓, IL-6↓, IL-1β ↓ |
Cerebral ischemia |
Brain |
Wang et al. (2016a)
|
Male Wistar rats |
BCCAO-induced brain damage |
In vivo
|
Glu↓, Asp↓, Gly↓, GABA↓, Tau↓, Ca 2+-ATPase↑ |
Cerebral ischemia |
Brain |
Tang et al. (2014)
|
|
|
|
Na +, K +-ATPase↑ |
|
|
|
SD rats |
— |
In vitro
|
p-VASP↑ |
Hypoxia |
Coronary artery |
Chen et al. (2015)
|
SD rats, |
Rats with cerebral I/R treatment |
In vivo
|
P-VASP↑, PKG↑ |
Hypoxia |
Brai |
Du et al. (2015)
|
HBMECs |
|
In vitro
|
|
|
|
|
Male SD rats, BV-2 cell |
MCAO-induced brain damage |
In vivo and in vitro
|
cyclin B1↑, cyclin B1↑, cyclin D1↑, NT-3↑ |
Cerebral ischemia |
Brain |
Fang et al. (2016)
|
|
|
|
IGF-1↑, AP-2↑, PSD-95↑ |
|
|
|
Male SD rats |
— |
In vivo
|
eNOS↑, p-Erk5↑, KLF2↑ |
Subarachnoid hemorrhage |
Brain |
Li et al. (2016)
|
Male SD rats |
LPS-induced behavioral deficits |
In vivo
|
ROS↓NLRP3, caspase-1, IL-1β↓ |
Depression |
Brain |
Bian et al. (2020)
|
Wistar rats |
— |
In vivo
|
IL-1β↓, IL-6↓, TNF-α↓, SOD↑, MAO↓ |
Depression |
Brain |
Guo et al. (2013)
|
Male C57BL/6 mice |
Depression-like behaviors |
In vivo
|
TNFα↓, IL-1β↓, IL-6↓, iNOS↓, IL-4↑, BDNF↑ |
Depression |
Brain |
Lu et al. (2021)
|
Primary astrocytes |
induced by LPS |
In vitro
|
|
|
|
|
Male C57BL/6 mice |
— |
In vivo
|
GABAA Rα1↓, GABAAγ2↓, mEPSC↓ |
Anxiety disorders |
Brain |
Guo et al. (2021)
|
MCF-7 cells |
— |
In vitro
|
Aggregation of beta-amyloid↓ |
Alzheimer's disease |
Brain |
Zhu et al. (2009)
|
Male APPswe/PS1dE9 mice |
— |
In vivo and in vitro
|
Aβ aggregation↑, soluble Aβ oligomers↓, Aβ42↓, Aβ40↓ |
Alzheimer's disease |
Brain |
Zhang et al. (2020)
|
C57BL/6 mice |
|
|
|
|
|
|
BV-2 cells |
— |
In vitro
|
NO↓, TNFα↓, IL-1β↓, ROS↓, iNOS↓, TNFα↓, IL-1β↓ |
Alzheimer's disease |
Brain |
Lu et al. (2021)
|
SH-SY5Y cells |
|
|
NF-κB↓, JNK↓, p38↓, IFN-γ↓, STAT1α↓ |
|
|
|
HT22 cell |
— |
In vivo and in vitro
|
Lactate dehydrogenase↓, lactate dehydrogenase↓, ROS↓, Aβ1‑42↑ |
Alzheimer's disease |
Brain |
Chiba et al. (2012)
|
Balb/c male mice |
|
|
p-Tau↓, ROS↓, Bcl-2↑, Bcl-xL↑, Bax↓, cleaved caspase-3↓ |
|
|
|
APP/PS1 transgenic mice |
— |
In vivo and in vitro
|
Aβ plaque↓, TNF-α↓, IL-6↓ |
Alzheimer's disease |
Brain |
Zeng et al. (2018)
|
WT mice, H-SY5Y cell line |
|
|
|
|
|
|
Male SD rats |
Permanent bilateral |
In vivo
|
Aβ (1-40) ↓, Aβ (1–42) ↓, Iba1↓ |
Vascular dementia |
Brain |
Shin et al. (2018)
|
|
Common carotid artery occlusion |
|
|
Alzheimer's disease |
|
|
Male Wistar rats |
|
In vivo
|
nAChR↑, nAChR α4↑, α7↑ |
Cognitive disorder |
Brain |
Guo et al. (2011b)
|
APP/PS1 transgenic mice |
— |
In vivo
|
SCFAs, IL-1β↓ |
Alzheimer's disease |
Brain |
Zhang et al., (2022c)
|
BALB/cmale mice |
— |
In vivo
|
MDA↓, SOD↑, IL-1β↓, IL-6↓, HO-1↓, NQO1↑, Nrf2↓ |
Alcohol induced brain injury |
Brain |
Zhang et al. (2022d)
|
BV-2 cells |
— |
In vitro
|
NF-κB-p65↓, TNF-α↓, IL-1β↓, IL-6↓, NO↓, TNF-α↓, IL-1β↓ |
neuroinflammation |
Brain |
You et al. (2018)
|
IL-6↓, iNOS↓, IκB↓, IKKβ↓, p38↓, JNK↓, AKT↓ |
Male albino Wistar rats |
— |
In vivo
|
MDA↓, SOD↑, GSH↑, AChE↓, NF-κB↓, TNFα↓, IL-6↓ |
Cognitive disorder |
Brain |
Baluchnejadmojarad et al. (2018)
|
Nrf2↑, beclin-1↓, LC3 II↓, mTOR↓, P62↓ |
Male C57BL/6 mice |
— |
In vivo and in vitro
|
nestin↑, Tuj-1↑, ERK1/2↑ |
Cognitive disorder |
Brain |
Wang et al. (2017)
|
Neural stem cells |
|
|
|
|
|
|
Male Wistar albino rats |
Metanil yellow induced |
In vivo
|
GFAP↓, cleaved caspase-3↓, MDA↓, SOD↑, GSH↑ |
Gliosis |
Brain |
Tawfeek et al. (2021)
|
Male SD rats |
— |
In vivo
|
TLR4↓, NF- κ B p65↓, TNF- α↓, IL-1 β↓, IL-18↓ |
Hypertension |
Brain |
Chen et al. (2013)
|
Bax↓, cleaved-caspase-3 p17↓, Mcl1↑ |
Male SD rats |
— |
In vivo
|
CTn-T↓, CTn-I↓, AST↓, LDH↓, SOD↑, CAT↑GSH↑ |
Myocardial infarction |
Heart |
Huang et al. (2018)
|
Caspase3↓, Caspase9↓, cytochrome C↓, NGAL↓, NFκB↓, IL-1β↓ |
P53↓, IL-6↓, Bcl2↑, MDA↓, iNOS↓, Bax↓ |
Male Wistar rats |
— |
In vivo
|
FN1↓, TGFβ1↓, CFs↓, p38-MAPK↓, ERK1/2↓ |
Cardiac fibrosis |
Heart |
Pan et al. (2011)
|
Male SD rats |
— |
In vivo
|
LVWI↓, RVWI↓, type I and type III collagen↓, MVD↑, CD31↑ |
Cardiac fibrosis |
Heart |
Zhou et al. (2014)
|
α-sma ↓, Jagged1↑, Notch 1↑, Hes1↑ |
C57BL/6 mice |
— |
In vitro and in vivo
|
CaMKII↓, β-MHC↑, ANP↑ |
Cardiac hypertrophy |
Heart |
Pan et al. (2010)
|
Cardiac myocytes |
|
|
|
|
|
|
SD rats, H9c2 cells |
— |
In vitro and in vivo
|
NLRP3↓, mTORC1↓, p-Akt↑, Casp-1↓, IL-1β↓ |
Myocardial I/R injury |
Heart |
Xu et al. (2020)
|
Rats, endothelial cell |
— |
In vitro and in vivo
|
P-JAK↓, P-STAT3↓ |
Myocardial I/R injury |
Heart |
Lin et al. (2014)
|
HCMECs |
— |
In vitro
|
JAK2↓, p-JAK2↓, STAT3↓, p-STAT3↓ |
Myocardial ischemia |
Heart |
Chen et al. (2019)
|
H9c2 cells |
— |
In vitro
|
JAK/STAT3↑, Bcl2↑, VEGF↑, MMP2↑, MMP9↑, TNFα↓ |
Myocardial I/R injury |
Heart |
Wang et al. (2016b)
|
IL-8↓, CK ↓, NO↑, ROS↓, SOD ↑, MDA ↓, STAT3↑, Bcl2↑ |
VEGF↑, MMP2↑, MMP9↑, IL-1β↓, IL-6↓ |
HCMECs |
— |
In vitro
|
EIF6↓, HSPD1↑, CCT6A↑ |
Anoxia |
Heart |
Shi et al. (2015)
|
HCMECs, SD rats |
MIR model |
In vitro and in vivo
|
PKG-I↑, PKG-Iα↑ |
Myocardial I/R injury |
Heart |
Li et al. (2015)
|
Male SD rats |
LPS induced lung injury |
In vivo
|
ROS↓, SOD↓, IL-1β↑, IL−18↑, IL−6↑, IL−4↑, IL−10↑, MDA↓ |
Lung injury |
Lung |
Fan et al. (2022)
|
Mice |
Injected with a dose of LPS |
In vivo
|
TNF-α↓, iNOS↓, c-Fos↓, iNOS↓, NF-kappaB↓, IkBa↓, GSH↑ |
Lung injury |
Lung |
Tan et al.(2010)
|
Male albino rats |
Rat Model of Bilateral |
In vivo
|
iNOS↑, Bax↑, Bcl2↓, COX2↓ |
Posterior limb I/R injury |
Lung |
Ibrahim et al. (2019)
|
|
Hind Limb I/R |
|
|
|
|
|
HBE-16 cell |
|
In vitro
|
MUC5AC↓, p-PKC↓, ERK1/2↓ |
Airway mucus secretion |
Lung |
Jiang et al. (2011b)
|
HBE-16 cell, Male SD rats |
|
In vivo and in vitro
|
MUC5AC↓, PKC↓, ERK1/2↓ |
Airway mucus secretion |
Lung |
Jiang et al. (2011a)
|
Male BALB/c mice |
BLM-induced |
In vivo and in vitro
|
p-p65/p65 ratio↓, IκBα↓NLRP3↓, caspase-1↓, caspase-11↓, IL-1β↓ |
Pulmonary fibrosis |
Lung |
Peng et al. (2020)
|
A549 cell, RLE-6TN cell |
|
|
IL-18↓, fibronectin↓, vimentin↓, N-cadherin↓, MMP-2↓, MMP-9↓ |
|
|
|
HK-2 cells, Wistar rats |
— |
In vitro and in vivo
|
HO-1↑, SCr↓, BUN↓, KIM-1↓, ROS↓ |
I/R injury |
kidney |
Dai et al. (2022)
|
HK-2 cells |
— |
In vitro
|
NGAL↓, Kim-1↓, cystatin C↓, IL-18↓, NLRP3↓, CCN1↑ |
Hyperuricemia |
kidney |
Li et al. (2020a)
|
Male C57BL/6 mice |
|
In vivo
|
|
|
|
|
Male C57BL/6 mice |
— |
In vivo
|
BUN↑, CRE↑, TNF-α↓, IL-6↓, Cleaved caspase-3↓ |
Chemotherapy toxicity |
kidney |
Sun et al. (2019)
|
Cleaved PARP↓, p53↓, Bax/Bcl-2↓, LC3-II/LC3-I↑, Atg7↑ |
p62↓JNK↓, ERK↓, p38↓, stat3↓ |
HepG2 cells |
Acid-treated HepG2 cells |
In vivo
|
XBP1↓, SREBP-1c↓, IRE1α↓ |
NAFLD |
Liver |
Zhang et al. (2022e)
|
C57/BL6 mice |
HFD-induced |
In vitro
|
|
|
|
|
HepG2 cells |
— |
In vitro
|
CD36↓, Fasn↓, ACC↓, AKT↑, mTOR↓, n-SREBP-1c↓ |
Hepatocyte lipid metabolism |
Liver |
Han and Wang (2018)
|
Male C57BL/6 mice |
|
In vivo
|
|
|
|
|
Mice |
HFD-induced |
In vivo and in vitro
|
SREBP-1c↓, mTOR↓ |
Hepatocyte lipid metabolism |
Liver |
Luan et al. (2020)
|
HepG2 cells |
PA-treated HepG2 cells |
|
|
|
|
|
Male C57BL/6 mice |
HFD induced mice |
In vivo and in vitro
|
PPARγ↑, PGC-1α↑, Nrf2↑, HO-1↑, GST↑, NQO1↑ |
NAFLD |
Liver |
Zhang et al. (2018)
|
HepG2 cells |
Oleic acid induced cells |
|
NF-κB↓, Keap1↓ |
|
|
|
SD rats |
HFD-induced |
In vivo
|
Nrf2, HO-1, and PI3K, and AKT ↑HO-1, NQO1, and Nrf2↑ |
NAFLD |
Liver |
Fan et al. (2017)
|
|
subjected to chronic stress |
|
|
|
|
|
BALB/c mice |
CCl4-induced liver injury |
In vivo
|
AST↓, ALT↓, TBIL↓, IL-1β↓, TNF-α↓, CYP2E1↓, IκBα/NF-κB↓ |
Hepatotoxicity |
Liver |
Miao et al. (2021)
|
S180 tumor-bearing mic |
DB-induced liver injury |
In vivo
|
MPO↑, IκB↓, NF-κB p65↓, TNF-α↓, IL-6↓, IFN-γ↓, MDA↓, GPx↑ |
Hepatotoxicity |
Liver |
Niu et al. (2015)
|
Male ICR mice |
Induced by concanavalin A |
In vivo
|
ALT↓, AST↓, TNF-α↓, iNOS↓, c-Fos↓, c-Jun↓, iNOS↓, IkappaB↑ |
Hepatitis autoimmune |
Liver |
Tan et al. (2007)
|
Male Wistar rats |
Se-treated rats |
In vivo
|
MDA↑, GSH-Px↑, TR↑ |
Hepatotoxicity |
Liver |
Eltayeb et al. (2004)
|
HL-7702 |
Under hypoxic condition |
In vitro
|
ROS↓, MDA↓, SOD↑, bcl-2↑, Keap1↓ Nrf2↑, HO-1↑, NQO1↑, Nrf2↓ |
I/R injury |
Liver |
Wu and Jia (2019)
|
Chondrocytes |
— |
In vitro
|
MMP1↓, MMP13↓, ADAMTS-5↓, Wnt3a↓, Frizzled7↓ |
Osteoarthritis |
Bones and joints |
Liu et al. (2020)
|
C57BL/6 male mice |
|
In vivo
|
Collagen II↑, Aggrecan↑ |
|
|
|
C57BL/6 mice |
— |
In vivo and in vitro
|
MMP-13↓, ADAMTS-5↓, COX-2↓, iNOS↓, IL-6↓, |
Osteoarthritis |
Bones and joints |
Luo et al. (2020)
|
Chondrocytes |
|
|
TNF-α↓, PGE2↓, IL-1β↓, NF-κB↑, Nrf2↑ |
|
|
|
BL6/C57 male mice |
— |
In vivo and in vitro
|
TNF-α↓, IL-1β↓, iNOS↓, MMP13↓, ADAMTS-5↓ |
Osteoarthritis |
Bones and joints |
Wang et al. (2019)
|
Chondrocyte cells |
|
|
COX-2↓, IL-6↓, NO↓ |
|
|
|
SW1353 cells |
— |
In vitro
|
IL-6↓, AKT↓, mTOR↓, p-mTOR↓, CH25H↓ |
Osteoarthritis |
Bones and joints |
Ju et al. (2021)
|
|
|
|
CYP7B1↓, ABCA1↑, APOA-1↑ |
|
|
|
Human Enucleus |
— |
In vivo and in vitro
|
ROS↓, NF-κB↓, MAPK↓, TNF-α↓, NLRP3↓ |
Intervertebral |
Bones and joints |
Wang et al. (2022b)
|
Pulposus Cells |
|
|
|
disc degeneration |
|
|
Male SD rats |
|
|
|
|
|
|
SD rats |
— |
In vivo and in vitro
|
ATG5↑, Rab8a↑, PI3K↑, PTEN↑, Akt↑ |
Intervertebral |
Bones and joints |
Hu et al. (2022)
|
Nucleus pulposus cells |
|
|
|
disc degeneration |
|
|
Male DBA/1J mice |
collagen‑induced arthritis |
In vivo
|
IL‑1β↓, IL‑6↓, TNF‑α↓, Caspase‑3/-9↓Bax/Bcl‑2↓TLR4↓NF‑κB↓ |
Arthritis |
Bones and joints |
Zhang et al., (2017)
|
Raw264.7 cell line |
— |
In vivo and in vitro
|
RANKL↓, MAPK↓, NF-κB↓, JNK1/2↓, p38↓, ERK1/2↓, IκBα↓ |
Arthritis |
Bones and joints |
Zhao et al. (2016)
|
C57BL/6 male mice |
|
|
|
|
|
|
Osteoblasts female SD rats |
— |
In vivo and in vitro
|
ALP secretion↑, intracellular calcium ion influx↑ |
Osteoporosis |
Bones and joints |
Wang et al. (2018)
|
|
|
|
calcium deposition↑, CXCR4↑, p65↑ |
|
|
|
3T3-L1 cells |
|
In vitro
|
PPARγ↓ C/EBPα↓ |
Obesity |
Metabolic disease |
Lu et al. (2013)
|
db/db mice db/m+ mice |
— |
In vivo
|
Nrf2↑, HO-1↑, IL-1β↓, IL-2↓, IL- 4↑ |
Diabetic Nephropathy |
Diabetic complication |
Liu et al. (2019b)
|
C57BL/6 male mice |
— |
In vitro and in vivo
|
laudin-1↑, claudin-19↑, NFκB↓, TNF-α↓, p-ERK 1/2↓, Nrf2↑ |
Diabetic retinopathy |
Diabetic complication |
Mei et al. (2019)
|
WT mice and HRECs |
|
|
|
|
|
|
Human retinal endothelial cells |
— |
In vitro
|
VEGF↓, p-ERK↓, p-FAK↓, p-Src↓ |
Diabetic retinopathy |
Diabetic |
Long et al. (2019)
|
Rats |
|
In vivo
|
|
|
complication |
|
Male Wistar rats |
— |
In vivo
|
MDA↓, ROS↓, Bcl-2↑, BAX↓, VEGF↑ |
Testicular Damages |
Diabetic |
Long et al. (2015)
|
|
|
|
|
|
complication |
|
Male SD rats |
— |
In vivo
|
blood glucose↓, TC↓, TG↓ LDL↓, HDL↑, LDH1↓, CK↓, |
Diabetic cardiomyopathy |
Diabetic |
Su et al. (2022)
|
|
|
|
Beclin-1↑, LC3-II↑ |
|
complication |
|
Male Swiss mice |
HFD-induced |
In vivo
|
CK-MB↓, Troponin↓, BNP↓, SOD↑, CAT↑, GPx↑, GST↑, Nrf2↓ |
Diabetic cardiomyopathy |
Diabetic |
Huo et al. (2021)
|
Nqo-1↓, Ho-1↓, Tlr4↓, Myd88↓, Nf-κb↓, IL-6↓, TNf-α↓, IKKβ↑ |
complication |
Cyt-c↓, Parp 1↓, bcl-2↑, caspase-3↓, caspase-9↓, Bax↓ |
HUVECs |
— |
In vitro
|
Bcl-2↓, Bax↓ Cyt c↓, ROS↑, SOD↑, SOD2↑, LC3 II↑, Beclin 1↑ |
Diabetic |
Diabetic |
Xi et al. (2021)
|
|
|
|
Atg 5↑, PINK1↑, Parkin↑, Mitofusin2↑ |
cardiomyopathy |
complicatio |
|
Male C57/B6 mice |
— |
In vivo
|
NLRP3↓, NF-κB↓, p-AKT↓, Nrf2↓, HO-1↓, EF↓, LVVd↓ |
Diabetic |
Diabetic |
Xu et al. (2021)
|
CK↓, Col I↓, TGF-β1↓, SOD↑, CAT↑, GSH-Px↑, MDA↓ |
cardiomyopathy |
complication |
ROS↓, IL-1β↓, IFN-γ↓, IL-6↓, MCP-1↓, TNF-α↓, IL-18↓ |
LDH↓, cTnI↓ |
LO2 |
Induced by Hcy |
In vivo and in vitro
|
Hcy↓, TG↓, CHO↓, LDL↓, ALT↓, AST↓, insulin↓, CBS↓, CSE↓ |
Diabetic |
Diabetic |
Wang et al. (2020)
|
Male SD rats |
High-fat induced |
|
MTHFR↓, folic acid↑, VitB6↑, VitB12↑ |
Liver Injury |
complication |
|
PC-9, H1975, Hela cells |
— |
In vitro
|
p-ERK1/2↑ ERK1/2↓, p-AKT↓, AKT↓, LC3-II↓ |
Lung cancer |
Cancer |
Sun et al. (2018a)
|
HepG2, Beas-2B cells |
|
|
p-ERK1/2↑, p-AKT↓ |
|
|
|
A549 cells |
— |
In vitro
|
G0/G1↓, AKT↓, mTOR↓, BCL-XL↓, STAT3↓, p-STAT3↓, 4EBP1↑ |
Lung cancer |
Cancer |
Cao et al. (2019)
|
A549 cells |
— |
In vitro
|
ROS↑, caspase-3↑, TGF-β1↓ |
Lung cancer |
Cancer |
Zhang et al. (2021)
|
HepG2 and MHCC97-H cells |
— |
In vitro
|
EMT↓, p-JAK2↓, p-STAT3↓ E‐cadherin↑, snail↓, vimentin↓ |
Liver cancer |
Cancer |
Liu et al. (2019a)
|
HepG2 and SK-Hep1 cells |
— |
In vitro
|
STAT3↓, Girdin↓, AKT↓ |
Liver cancer |
Cancer |
Ke et al. (2017)
|
Male BALB/c nude mice |
|
In vivo
|
|
|
|
|
C57BL/6 male mice |
CAC caused by AOM/DSS |
In vivo and in vitro
|
NF-κB↓, SHH↓, Ptch1↓, Smo↓, Gli1↓ |
Colorectal cancer |
Cancer |
Zeng et al. (2022)
|
SW480 cells |
|
|
|
|
|
|
SW620, HCT116, LOVO |
— |
In vitro and in vivo
|
ephrinb2↓, ephB6↓, ephA1↓ |
Colorectal cancer |
Cancer |
Zhu et al. (2017) |
HT29 cells and Balb/c nude mice |
|
|
|
|
|
|
HT-29 CSC cells |
— |
In vitro and in vivo
|
Lgr5↓, c-Myc↓, CK20↓, Nanog↓, Gli1↓, CD133↓, Lgr5↓ |
Colorectal cancer |
Cancer |
Lei et al. (2020)
|
Nude mice |
|
|
Gli1↓, Ptch1↓, c-Myc↓, Ki-67↓, CK20↓ |
|
|
|
HCT116 p53+/+ (wild-type) |
— |
In vitro
|
caspase-6↑ |
Colorectal cancer |
Cancer |
Chan et al. (2009) |
p53-/- (knockout) cells |
|
|
|
|
|
|
Male C57BL/6 mice |
Induced by azoxymethane and |
In vivo
|
Wnt/β-catenin↓, TNF-α↓, IL-6↓, Bax↑ |
Colorectal cancer |
Cancer |
Zeng et al. (2021)
|
HT-29 cells |
dextran sulfate sodium |
In vitro
|
Bcl-2↓, GSK-3β↓, cyclin D1↓ |
|
|
|
Mice |
— |
In vivo
|
p38 MAPK↓, TNFR2+Tregs↓, CD8+T↑ |
Colorectal cancer |
Cancer |
Chen et al. (2022)
|
WEHI-13VAR and CT26 cell |
|
In vitro
|
|
|
|
|
HCT‑116 cells |
— |
In vitro
|
Bcl‑2↓, Bax↑, caspase‑3↑, p-p53↑ |
Colorectal cancer |
Cancer |
Yang et al. (2017)
|
AGS |
— |
In vitro and in vivo
|
LDH↓, G0-G1↑S↓, G2-M↓, SOD↑, GSH↑, CAT↑, MDA↓, 8-OHdG↓ |
Gastric cancer |
Cancer |
Sun and Meng (2022)
|
MGC-803 and AGS |
— |
In vitro
|
PI3K↓, PTEN↑ |
Gastric cancer |
Cancer |
Li et al. (2021)
|
SAS cells |
— |
In vitro and in vivo
|
MMP-2 and -9↓, integrin αvβ6↓, c-JUN↓ |
Oral squamous cell carcinoma |
Cancer |
Li et al. (2013)
|
Athymic Balb/ca nude mice |
|
|
|
|
|
|
SAS and HSC-4 cells |
— |
In vitro
|
E-cadherin↑, αvβ6 integrin↓ |
Oral squamous cell carcinoma |
Cancer |
Li et al. (2010)
|
C57BL/6J mice |
— |
In vivo
|
retinal thinning and reduced visual behavioral deficits |
Glaucoma |
Eye |
Pang and Clark (2020)
|
Female C57BL/6 mice |
LPS-primed macrophages |
In vivo and in vitro
|
NLRP3↓, IL-1β↓, caspase-1 ↓ |
Sepsis |
Multiple Organ |
Liu et al. (2017)
|